COLM

Columbia is a fundamentally sound but stalled franchise being priced as such. FY2025 revenue of $3.40B grew just 0.9% YoY and remains below the FY2023 peak of $3.49B, while net income fell to $177M (-20.6% YoY) and operating income dropped -23.5% to $207M — a 6.1% operating margin that confirms management's own MD&A admission that the Columbia brand in the U.S. is 'under pressure' from casualization/athleisure competitors. The ACCELERATE Growth Strategy and 'Engineered for Whatever' relaunch are real, but management only cites 'early indicators' — not numbers — so the turn is unproven.

The balance sheet is the saving grace and the reason this isn't a sell. Equity of $1.71B against $1.22B of liabilities (0.71x L/E), $442M cash, and a current ratio of ~2.6x give the company room to weather the tariff storm management calls out repeatedly as 'rapidly evolving' with 'significant uncertainty' around the new 122 tariffs and refunds of prior tariffs paid. The 10-K explicitly flags that tariff-driven order cancellations for Fall 2025 and Spring 2026 have already misaligned demand and supply — that is a forward warning, not a one-time hit, and explains why OCF collapsed -42.4% to $283M even as revenue ticked up.